Your browser doesn't support javascript.
loading
Modeled Hepatic/Plasma Exposures of Omeprazole Prescribed Alone in Cytochrome P450 2C19 Poor Metabolizers Are Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database.
Adachi, Koichiro; Ohyama, Katsuhiro; Tanaka, Yoichi; Murayama, Norie; Shimizu, Makiko; Saito, Yoshiro; Yamazaki, Hiroshi.
Affiliation
  • Adachi K; Showa Pharmaceutical University.
  • Ohyama K; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
  • Tanaka Y; National Institute of Health Sciences.
  • Murayama N; Showa Pharmaceutical University.
  • Shimizu M; Showa Pharmaceutical University.
  • Saito Y; National Institute of Health Sciences.
  • Yamazaki H; Showa Pharmaceutical University.
Biol Pharm Bull ; 47(5): 1028-1032, 2024.
Article in En | MEDLINE | ID: mdl-38797695

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Omeprazole / Proton Pump Inhibitors / Cytochrome P-450 CYP2C19 / Liver Limits: Humans Country/Region as subject: Asia Language: En Journal: Biol Pharm Bull Journal subject: BIOQUIMICA / FARMACOLOGIA Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Omeprazole / Proton Pump Inhibitors / Cytochrome P-450 CYP2C19 / Liver Limits: Humans Country/Region as subject: Asia Language: En Journal: Biol Pharm Bull Journal subject: BIOQUIMICA / FARMACOLOGIA Year: 2024 Type: Article